Dale K. Heuer, MD
Professor & Chairman, Department of Ophthalmology
Director, Eye Institute
Phone: (414) 955-2020
FAX: (414) 955-6300
E-mail: dheuer@mcw.edu
Address:
The Eye Institute
925 N. 87th St.
Milwaukee, WI. 53226
Patient Care Emphasis
-
Glaucoma
-
Ocular Hypertension
-
Hypotony
-
Congenital, Infantile, and Pediatric Glaucomas
-
Normal Pressure Glaucoma
-
Surgical Management of Glaucoma
Current Research Interests
-
Vice-Chair, National Eye Institute-funded Ocular Hypertension Treatment Study
-
Aqueous Shunting Procedures
-
Initial Treatment of Glaucoma
-
Ocular Hypertension
-
Normal Pressure Glaucoma
Honors and Society Memberships
-
Best Doctors in America, 1st, 2nd, 3rd, & 4th Editions
-
Honor Award, American Academy of Ophthalmology
-
American Academy of Ophthalmology
-
American Glaucoma Society
-
Association for Research in Vision and Ophthalmology
-
Association of University Professors of Ophthalmology
-
Christian Medical and Dental Society
-
Milwaukee Academy of Medicine
-
Milwaukee Ophthalmological Society
-
Research to Prevent Blindness
-
Wisconsin Academy of Ophthalmology
Education
-
MD, Northwestern University Medical School, Chicago, IL
Post Graduate Training
-
Internship, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
-
Residency, Ophthalmology, Medical College of Wisconsin - Eye Institute, Milwaukee, WI
-
Clinical Fellowship, Glaucoma, Bascom Palmer Eye Institute, Miami, FL
-
Research Fellowship, Glaucoma, Bascom Palmer Eye Institute, Miami, FL
Recent Publications
Han DP, Heuer DK. Intravitreal corticosteroid therapy: putting the problem of glaucoma in perspective. Arch Ophthalmol. 2012 Mar;130(3):380-2.
Brandt JD, Gordon MO, Gao F, Beiser JA, Miller JP, Kass MA, for the Ocular Hypertension Treatment Study Group Ophthalmology: Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma. Ophthalmology 2012;119:437-442.111.
Gedde SJ, Parrish RK II, Budenz DL, Heuer DK: Update on aqueous shunts. Exp Eye Res 2011;93:284-290.
Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R, for the CIGTS Study Group: Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2011;118:1766–1773.
Chen PP, Musch DC, Niziol L for the CIGTS Study Group: The effect of early posttrabeculectomy intraocular pressure spike in the Collaborative Initial Glaucoma Treatment Study. J Glaucoma 2011;20:211–214.
Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM, for the Ahmed Baerveldt Comparison Study Group: Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology 2011;118:443–452.
Barton K, Gedde SJ, Budenz DL, Feuer WJ, Schiffman J, for the Ahmed Baerveldt Comparison Study Group: The Ahmed Baerveldt Comparison Study: Methodology, baseline patient characteristics, and intraoperative complications. Ophthalmology 2011;118:435–442.
Gao F, Miller JP, Xiong C, Beiser JA, Gordon M, the Ocular Hypertension Treatment Study (OHTS) Group: A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome. Stat Methods Appl 2011;20:83–100.
Artes PH, Chauhan BC, Keltner JL, Cello KE, Johnson CA, Anderson DR, Gordon MO, Kass MA, for the Ocular Hypertension Treatment Study Group: Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol 2010;128:1528-1532.
Radcliffe NM, Musch DC, Niziol LM, Liebmann JM, Ritch R, MD, on behalf of the Collaborative Initial Glaucoma Treatment Study Group: The effect of trabeculectomy on intraocular pressure of the untreated fellow eye in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2010;117:2055–2060.
Bhorade AM, Wilson BS, Gordon MO, Palmberg P, Weinreb RN, Miller E, Chang RT, Kass MA, for the Ocular Hypertension Treatment Study Group: The utility of the monocular trial. Data from the Ocular Hypertension Treatment Study. Ophthalmology 2010;117:2047–2054.
Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO, for the Ocular Hypertension Treatment Study Group: The Incidence of Retinal Vein Occlusion in the Ocular Hypertension Treatment Study. Ophthalmology 2010;117:484–488.
Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR, for the Ocular Hypertension Treatment Study Group: Delaying Treatment of Ocular Hypertension. The Ocular Hypertension Treatment Study. Arch Ophthalmol 2010;128:276-287.
Gedde SJ, Heuer DK, Parrish RK II; the Tube Versus Trabeculectomy Study Group: Review of results from the Tube Versus Trabeculectomy Study. Curr Opin Ophthalmol 2010;21:123-128.
Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL, on behalf of the Tube Versus Trabeculectomy Study Group: Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol 2009;148:670-684.
Bhorade AM, Gordon MO, Wilson B, Weinreb RN, Kass MA for the Ocular Hypertension Treatment Study Group: Variability of intraocular pressure measurements in observation participants in the Ocular Hypertension Treatment Study. Ophthalmology 2009;116:717-724.
Janz NK, Musch DC, Gillespie BW, Wren PA, Niziol LM, for the Collaborative Initial Glaucoma Treatment Study (CIGTS) Investigators: Evaluating clinical change and visual function concerns in drivers and nondrivers with glaucoma. Invest Ophthalmol Vis Sci 2009;50:1718–1725.
Parrish RK II, Feuer WJ, Schiffman JD, Lichter PR, Musch DC, on behalf of the CIGTS Optic Disc Study Group: Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol 2009;147:717-724.
Rauscher FM, Gedde SJ, Schiffman JC, Feuer WJ, Barton K, Lee RK, on behalf of The Tube Versus Trabeculectomy Study Group: Motility disturbances in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol 2009;147:458-466.
Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK, the CIGTS Study Investigators: Visual field progression in the Collaborative Initial Glaucoma Treatment Study. The impact of treatment and other baseline factors. Ophthalmology 2009;116:200-207.
Brandt JD, Gordon MO, Beiser JA, Lin SC, Alexander MY, Kass MA, Ocular Hypertension Treatment Study Group: Changes in central corneal thickness over time. The Ocular Hypertension Treatment Study. Ophthalmology 2008:115:1550-1556.
Musch DC, Gillespie BW, Niziol LM, Cashwell LF, Lichter PR for the Collaborative Initial Glaucoma Treatment Study Group: Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2008;115:927-923.